302 related articles for article (PubMed ID: 25026126)
1. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease.
Aykut A; Onay H; Kose M; Erbas Canda E; Karaca E; Coker M; Ozkinay F
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1265-7. PubMed ID: 25026126
[TBL] [Abstract][Full Text] [Related]
2. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations.
Fu L; Qiu W; Yu Y; Guo Y; Zhao P; Zhang X; Liu C; Li F; Huang H; Huang M; Chen S
Gene; 2014 Feb; 535(1):53-9. PubMed ID: 24269976
[TBL] [Abstract][Full Text] [Related]
4. Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients.
Park HD; Lee DH; Choi TY; Lee YK; Lee SY; Kim JW; Ki CS; Lee YW
Ann Clin Lab Sci; 2013; 43(3):311-6. PubMed ID: 23884227
[TBL] [Abstract][Full Text] [Related]
5. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
6. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
[TBL] [Abstract][Full Text] [Related]
7. Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings.
Teng YT; Su WJ; Hou JW; Huang SF
Chang Gung Med J; 2004 May; 27(5):379-84. PubMed ID: 15366815
[TBL] [Abstract][Full Text] [Related]
8. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
[TBL] [Abstract][Full Text] [Related]
9. Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy.
Cho A; Kim SJ; Lim BC; Hwang H; Park JD; Kim GB; Jin DK; Lee J; Ki CS; Kim KJ; Hwang YS; Chae JH
J Child Neurol; 2012 Mar; 27(3):319-24. PubMed ID: 21940687
[TBL] [Abstract][Full Text] [Related]
10. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
[TBL] [Abstract][Full Text] [Related]
11. The genotype-phenotype correlation in Pompe disease.
Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
[TBL] [Abstract][Full Text] [Related]
12. A novel missense mutation in the acid alpha-glucosidase gene causing the classic infantile form of Pompe disease.
Dou W; Peng C; Zheng J; Gu X; Fu L; Martiniuk F; Sheng HZ
Clin Chim Acta; 2006 Dec; 374(1-2):145-6. PubMed ID: 16782080
[No Abstract] [Full Text] [Related]
13. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
14. Detection of a novel mutation in the GAA gene in an Iranian child with glycogen storage disease type II.
Galehdari H; Emami M; Mohammadian G; Khodadadi A; Azmoon S; Baradaran M
Arch Iran Med; 2013 Feb; 16(2):126-8. PubMed ID: 23360637
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and molecular genetic study on two patients of the juvenile form of Pompe disease in China].
Qiu JJ; Wei M; Zhang WM; Shi HP
Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):760-4. PubMed ID: 18211760
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.
Herzog A; Hartung R; Reuser AJ; Hermanns P; Runz H; Karabul N; Gökce S; Pohlenz J; Kampmann C; Lampe C; Beck M; Mengel E
Orphanet J Rare Dis; 2012 Jun; 7():35. PubMed ID: 22676651
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1G>C mutation.
Gort L; Coll MJ; Chabás A
Mol Genet Metab; 2007; 92(1-2):183-7. PubMed ID: 17616415
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation.
But WM; Lee SH; Chan AO; Lau GT
Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354
[TBL] [Abstract][Full Text] [Related]
19. A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease).
Aryani O; Manshadi MD; Tondar M; Khalili E; Kamalidehghan B; Ahmadipour F; Fani S; Houshmand M
Mol Biol Rep; 2014 Sep; 41(9):6211-4. PubMed ID: 24976573
[TBL] [Abstract][Full Text] [Related]
20. Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand.
Ngiwsara L; Wattanasirichaigoon D; Tim-Aroon T; Rojnueangnit K; Noojaroen S; Khongkraparn A; Sawangareetrakul P; Ketudat-Cairns JR; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Svasti J
BMC Med Genet; 2019 Sep; 20(1):156. PubMed ID: 31510962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
